Global Demand for Remdesivir Market to Grow at a Lucrative CAGR – Zion Market Research

Zion Market Research has published a new report titled “Remdesivir Market by Dosage (2.5mg, 5mg, 100mg, 200mg ); by Patient (Adult, Pediatric, and Geriatric); by Application (Ebola, SARS-COV, MERS-COV, COVID-19); By End user (Hospitals, Clinics, Pharmacy & Drug Stores, Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026”.

Remdesivir is an analog investigational nucleotide having broad-spectrum antiviral activity in animal models both in vitro and in vivo against several rapidly growing viral pathogens like Ebola, Marburg, MERS and SARS. Gilead in vitro testing has shown that remdesivir is effective against the virus which causes COVID-19. Remdesivir’s safety and efficacy for COVID-19 therapy is being tested in several ongoing Phase 3 clinical trials. Remdesivir is investigative as it is still under investigation. There is limited knowledge about the safety and efficacy about using Remdesivir to treat patients with COVID-19 at hospital. There are no FDA-approved medicines as safe and effective for treating people who have COVID-19 in hospital. The FDA has therefore authorized Remdesivir ‘s emergency use for the treatment of COVID-19 under an Emergency Use Authorisation (EUA).

Occurrences of pandemics like COVID-19, Ebola, and growing prevalence of viral diseases will act as major driving factors in the growth of global Remdesivir market. High investment in research and development to investigate for further uses of Remdesivir will act as an opportunity for the market players in the Remdesivir market. Nonetheless, high cost of Remdesivirs will restrict the growth of global Remdesivir market.

The global Remdesivir market has been fragmented into Dosage, Patient, Application, End user, and region. Based on Dosage, Global Remdesivir Market is segmented into 2.5mg, 5mg, 100mg, and 200mg. Based on Patient, Market is segmented into Adult, Pediatric, and Geriatric. Based on Application, Market is segmented into Ebola, SARS-COV, MERS-COV, COVID-19. The End user segment of the Remdesivir Market is categorized into Hospitals, Clinics, Pharmacy & Drug Stores, Online Pharmacies.

Get Sample of this Research Report for more Insights – https://www.zionmarketresearch.com/sample/remdesivir-market

Region wise, the Remdesivir market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. Increasing cases of covid-19, High prevalence of diseases, easy availability, and presence of leading market players will boost the market growth in this region. Europe will be the second largest market. The major reasons are increasing awareness concerning use of Remdesivir and high impact of pandemics like COVID-19. Asia Pacific will proliferate at speedy rate over the forecast period due to high frequencies of viral disease outbreak, and granting of permission to manufacture Remdesivir by the parent company. Latin America market will progress at a notable rate during the estimate period. The Middle Eastern and African countries are expected to experience clear growth in the predictable time.

The report also includes detailed profiles of key players such Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Hetero, Cipla, Jubilant Lifesciences among others.

Get Covid-19 Impact Analysis – https://www.zionmarketresearch.com/custom/5358?covid19=true

The report segment of global Remdesivir market as follows:

Global Remdesivir Market: By Dosage

• 2.5mg
• 5mg
• 100mg
• 200mg

Global Remdesivir Market: By Patient

• Adult
• Pediatric
• Geriatric

Global Remdesivir Market: By Application

• Ebola
• SARS-COV
• MERS-COV
• COVID-19
  • Invasive mechanical ventilation
  • Non-Invasive mechanical ventilation

Global Remdesivir Market: By End user

• Hospitals
• Clinics
• Pharmacy & Drug Stores
• Online Pharmacies

Global Remdesivir Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.